• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于合成和先导优化硫取代蒽[1,2-c][1,2,5]噻二唑-6,11-二酮衍生物的环融合策略,该衍生物是有前景的抗肿瘤药物骨架。

Ring fusion strategy for synthesis and lead optimization of sulfur-substituted anthra[1,2-c][1,2,5]thiadiazole-6,11-dione derivatives as promising scaffold of antitumor agents.

作者信息

Lee Yu-Ru, Chen Tsung-Chih, Lee Chia-Chung, Chen Chun-Liang, Ahmed Ali Ahmed Atef, Tikhomirov Alexander, Guh Jih-Hwa, Yu Dah-Shyong, Huang Hsu-Shan

机构信息

Graduate Institute of Life Sciences, National Defense Medical Center, Taipei 114, Taiwan; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 110, Taiwan.

Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 110, Taiwan.

出版信息

Eur J Med Chem. 2015 Sep 18;102:661-76. doi: 10.1016/j.ejmech.2015.07.052. Epub 2015 Aug 7.

DOI:10.1016/j.ejmech.2015.07.052
PMID:26344783
Abstract

A series of sulfur-substituted anthra[1,2-c][1,2,5]thiadiazole-6,11-diones were synthesized and evaluated using the cell proliferations, apoptosis and NCI-60 cell panel assays. Also, the signaling pathways that account for their activities were investigated. Compounds 2, 3, 4a, 4d, 4f, 4i, 4k, 5b, 5c, 5d, 5f, 5g, 6b, 6c, 6d, 6e, 6g, 7a and 7g were selected by NCI. Among the tested compounds, 6g appeared to be the most active compound of this series that not only induced apoptosis in DU-145 cancer cells but also attenuated the ERK1/2 and p38 signaling pathways. All test compounds exhibited diverse cytostatic and cytotoxic activities that warrant further development as potential anticancer agents.

摘要

合成了一系列硫取代的蒽[1,2 - c][1,2,5]噻二唑 - 6,11 - 二酮,并通过细胞增殖、凋亡和NCI - 60细胞系检测进行评估。此外,还研究了导致其活性的信号通路。化合物2、3、4a、4d、4f、4i、4k、5b、5c、5d、5f、5g、6b、6c、6d、6e、6g、7a和7g被NCI选中。在所测试的化合物中,6g似乎是该系列中最具活性的化合物,它不仅能诱导DU - 145癌细胞凋亡,还能减弱ERK1/2和p38信号通路。所有测试化合物均表现出不同的细胞生长抑制和细胞毒性活性,值得作为潜在的抗癌药物进一步开发。

相似文献

1
Ring fusion strategy for synthesis and lead optimization of sulfur-substituted anthra[1,2-c][1,2,5]thiadiazole-6,11-dione derivatives as promising scaffold of antitumor agents.用于合成和先导优化硫取代蒽[1,2-c][1,2,5]噻二唑-6,11-二酮衍生物的环融合策略,该衍生物是有前景的抗肿瘤药物骨架。
Eur J Med Chem. 2015 Sep 18;102:661-76. doi: 10.1016/j.ejmech.2015.07.052. Epub 2015 Aug 7.
2
Structure-based design, synthesis and biological evaluation of novel anthra[1,2-d]imidazole-6,11-dione homologues as potential antitumor agents.基于结构的新型蒽[1,2-d]咪唑-6,11-二酮类似物的设计、合成与生物评价及其作为潜在抗肿瘤剂的研究。
Eur J Med Chem. 2013 Nov;69:278-93. doi: 10.1016/j.ejmech.2013.06.058. Epub 2013 Aug 9.
3
Design, synthesis and evaluation of 4-substituted anthra[2,1-c][1,2,5]thiadiazole-6,11-dione derivatives as novel non-camptothecin topoisomerase I inhibitors.新型非喜树碱类拓扑异构酶I抑制剂4-取代蒽[2,1-c][1,2,5]噻二唑-6,11-二酮衍生物的设计、合成与评价
Bioorg Med Chem Lett. 2017 May 1;27(9):1929-1933. doi: 10.1016/j.bmcl.2017.03.039. Epub 2017 Mar 18.
4
Ring fusion strategy for the synthesis of anthra[2,3-d]oxazole-2-thione-5,10-dione homologues as DNA topoisomerase inhibitors and as antitumor agents.用于合成蒽[2,3-d]恶唑-2-硫酮-5,10-二酮同系物的环融合策略,该同系物可作为DNA拓扑异构酶抑制剂和抗肿瘤剂。
Eur J Med Chem. 2014 Nov 24;87:30-8. doi: 10.1016/j.ejmech.2014.09.016. Epub 2014 Sep 6.
5
Natural product-based design, synthesis and biological evaluation of anthra[2,1-d]thiazole-6,11-dione derivatives from rhein as novel antitumour agents.从瑞香素出发的基于天然产物的设计、合成和生物评价新型抗肿瘤剂蒽[2,1-d]噻唑-6,11-二酮衍生物。
Eur J Med Chem. 2014 Sep 12;84:505-15. doi: 10.1016/j.ejmech.2014.07.047. Epub 2014 Jul 15.
6
Synthesis, cytotoxicity and human telomerase inhibition activities of a series of 1,2-heteroannelated anthraquinones and anthra[1,2-d]imidazole-6,11-dione homologues.一系列 1,2-杂环并蒽醌和蒽[1,2-d]咪唑-6,11-二酮类似物的合成、细胞毒性及对人端粒酶的抑制活性。
Bioorg Med Chem. 2009 Nov 1;17(21):7418-28. doi: 10.1016/j.bmc.2009.09.033. Epub 2009 Sep 23.
7
Synthesis and antitumor-evaluation of 1,3-selenazole-containing 1,3,4-thiadiazole derivatives.含 1,3-硒唑基的 1,3,4-噻二唑衍生物的合成与抗肿瘤活性评价。
Bioorg Med Chem Lett. 2013 Dec 15;23(24):6577-9. doi: 10.1016/j.bmcl.2013.10.062. Epub 2013 Nov 6.
8
Synthesis and anticancer evaluation of novel 2-cyclopropylimidazo[2,1-b][1,3,4]-thiadiazole derivatives.新型 2-环丙基咪唑[2,1-b][1,3,4]噻二唑衍生物的合成及抗癌活性评价。
Eur J Med Chem. 2011 Sep;46(9):4411-8. doi: 10.1016/j.ejmech.2011.07.012. Epub 2011 Jul 8.
9
Novel diosgenin derivatives containing 1,3,4-oxadiazole/thiadiazole moieties as potential antitumor agents: Design, synthesis and cytotoxic evaluation.新型含 1,3,4-噁二唑/噻二唑结构的薯蓣皂苷元衍生物作为潜在的抗肿瘤药物:设计、合成与细胞毒性评价。
Eur J Med Chem. 2020 Jan 15;186:111897. doi: 10.1016/j.ejmech.2019.111897. Epub 2019 Nov 18.
10
Synthesis and biological evaluation of novel 2-aralkyl-5-substituted-6-(4'-fluorophenyl)-imidazo[2,1-b][1,3,4]thiadiazole derivatives as potent anticancer agents.新型 2-芳基烷基-5-取代-6-(4'-氟苯基)-咪唑[2,1-b][1,3,4]噻二唑衍生物的合成及生物评价作为有效的抗癌剂。
Eur J Med Chem. 2011 Jun;46(6):2109-16. doi: 10.1016/j.ejmech.2011.02.064. Epub 2011 Mar 4.

引用本文的文献

1
Redefining Anthraquinone-based Anticancer Drug Design through Subtle Chemical Modifications.通过精细化学修饰重新定义基于蒽醌的抗癌药物设计
Anticancer Agents Med Chem. 2025 Mar 3. doi: 10.2174/0118715206374787250227064528.
2
A review on potential heterocycles for the treatment of glioblastoma targeting receptor tyrosine kinases.关于针对受体酪氨酸激酶的治疗胶质母细胞瘤的潜在杂环的综述。
Oncol Res. 2024 Apr 23;32(5):849-875. doi: 10.32604/or.2024.047042. eCollection 2024.
3
Comprehensive Omics Analysis of a Novel Small-Molecule Inhibitor of Chemoresistant Oncogenic Signatures in Colorectal Cancer Cell with Antitumor Effects.
全面组学分析新型小分子抑制剂对结直肠癌细胞耐药致癌特征的抗肿瘤作用
Cells. 2021 Aug 3;10(8):1970. doi: 10.3390/cells10081970.
4
Thiadiazole derivatives as anticancer agents.噻二唑衍生物作为抗癌剂。
Pharmacol Rep. 2020 Oct;72(5):1079-1100. doi: 10.1007/s43440-020-00154-7. Epub 2020 Sep 3.
5
CC12 Induces Apoptotic Cell Death and Cell Cycle Arrest in Human Glioblastoma Cell Lines and Mouse Xenograft Model.CC12 诱导人胶质母细胞瘤细胞系和小鼠异种移植模型中的细胞凋亡和细胞周期停滞。
Molecules. 2020 Apr 14;25(8):1793. doi: 10.3390/molecules25081793.
6
RV-59 suppresses cytoplasmic Nrf2-mediated 5-fluorouracil resistance and tumor growth in colorectal cancer.RV-59抑制结直肠癌中细胞质Nrf2介导的5-氟尿嘧啶耐药性和肿瘤生长。
Am J Cancer Res. 2019 Dec 1;9(12):2789-2796. eCollection 2019.
7
Identification and preclinical evaluation of the small molecule, NSC745887, for treating glioblastomas via suppressing DcR3-associated signaling pathways.小分子NSC745887通过抑制DcR3相关信号通路治疗胶质母细胞瘤的鉴定及临床前评估
Oncotarget. 2017 Dec 27;9(15):11922-11937. doi: 10.18632/oncotarget.23714. eCollection 2018 Feb 23.
8
Novel Anthra[1,2-c][1,2,5]Thiadiazole-6,11-Diones as Promising Anticancer Lead Compounds: Biological Evaluation, Characterization & Molecular Targets Determination.新型蒽[1,2-c][1,2,5]噻二唑-6,11-二酮作为有前景的抗癌先导化合物:生物学评价、表征及分子靶点确定
PLoS One. 2016 Apr 21;11(4):e0154278. doi: 10.1371/journal.pone.0154278. eCollection 2016.